- βLibre 3 Plus offers 15-day wear vs 14-day on the original Libre 3
- βImproved MARD accuracy of ~7.4% for more reliable glucose readings
- βNew Urgent Low alarm at 55 mg/dL enhances safety for insulin users
Libre 3 Plus vs Libre 3: What Changed?
Abbott's FreeStyle Libre family has long been a favorite among people with diabetes who want a discreet, affordable, and reliable continuous glucose monitor (CGM). When the Libre 3 launched, it set a new standard for sensor size and real-time readings. Now, the Libre 3 Plus takes things a step further. But what exactly changed, and is it worth the upgrade?
A Quick Recap: The FreeStyle Libre 3
The FreeStyle Libre 3 was already a significant leap forward when it arrived. It featured:
- The world's smallest CGM sensor at the time of launch
- Real-time glucose readings sent directly to a smartphone every minute
- A 14-day wear period
- A Mean Absolute Relative Difference (MARD) of 7.9%, indicating strong accuracy
- No fingerstick calibration required
- Optional high and low glucose alarms
For many users, the Libre 3 represented the sweet spot between affordability and performance. Supplies are readily available through retailers like mdsdiabetes.com, making it accessible to a wide range of patients.
What's New with the Libre 3 Plus?
The Libre 3 Plus builds on this solid foundation with several meaningful improvements:
1. Extended Wear Time: 15 Days
One of the most practical upgrades is the jump from 14 to 15 days of continuous wear. While one extra day might sound minor, it adds up over time β fewer sensor changes per year means less hassle and potentially lower costs.
2. Improved Accuracy
The Libre 3 Plus boasts an even lower MARD of approximately 7.4%, compared to the Libre 3's 7.9%. A lower MARD means glucose readings are closer to laboratory reference values, which can be especially important when making insulin dosing decisions.
3. Urgent Low Alarm
The Libre 3 Plus introduces a dedicated Urgent Low alarm that alerts users when glucose drops to a critically dangerous level (55 mg/dL). This is a significant safety feature, particularly for individuals who experience hypoglycemia unawareness.
4. Enhanced Connectivity and App Experience
Abbott refined the companion app for the Libre 3 Plus, improving Bluetooth stability and providing a smoother user experience. The app continues to support data sharing with caregivers and healthcare providers through LibreLinkUp.
5. iCGM Designation
The Libre 3 Plus received FDA designation as an integrated CGM (iCGM), meaning it can work in tandem with compatible automated insulin delivery (AID) systems. This opens the door for closed-loop integration that the standard Libre 3 did not support in the same way.
Side-by-Side Comparison
| Feature | Libre 3 | Libre 3 Plus |
|---|---|---|
| Wear Time | 14 days | 15 days |
| MARD | 7.9% | ~7.4% |
| Urgent Low Alarm | No | Yes (55 mg/dL) |
| iCGM Designation | No | Yes |
| Calibration Required | No | No |
| Scan Required | No | No |
Who Should Upgrade?
If you are currently using the Libre 3 and are satisfied with its performance, the Libre 3 Plus offers meaningful incremental improvements rather than a complete overhaul. The Urgent Low alarm and iCGM compatibility are the most compelling reasons to switch, especially for users on insulin or those exploring automated insulin delivery systems.
If you're new to CGM technology and deciding between the two, the Libre 3 Plus is the clear choice for its added safety features and better accuracy.
Final Thoughts
Abbott continues to refine its Libre lineup with each generation, and the Libre 3 Plus is a worthwhile evolution. Greater accuracy, longer wear, and critical safety alarms make it a strong option for anyone managing diabetes. Whether you're upgrading or starting fresh, exploring CGM options through trusted suppliers is always a smart move for consistent access to your devices.